SFR1 Activators
SFR1 activators are a class of chemical compounds that interact with the SFR1 protein, a component of the cellular machinery that is involved in various biological processes. SFR1, short for "Stimulator of Fe-S Protein 1," plays a critical role in the biogenesis of iron-sulfur (Fe-S) clusters. These clusters are inorganic cofactors crucial for many cellular functions, including electron transport in mitochondria, DNA repair, and regulation of gene expression. SFR1 activators, by definition, bind to or influence the SFR1 protein in such a way that they modulate its activity, leading to an increase in the functional output of the protein. The chemical nature of these activators can be diverse, ranging from small organic molecules to larger biochemical entities, and their mode of action can be direct, through binding to the SFR1 protein, or indirect, through affecting the pathway or environment in which SFR1 operates.
The specificity and selectivity of SFR1 activators are paramount for their ability to precisely modulate the function of SFR1. The interaction between these chemical compounds and the SFR1 protein is governed by the principles of molecular recognition, which involves the structural complementarity between the activator molecule and the specific binding sites on the SFR1 protein. This interaction is typically characterized by a combination of non-covalent forces, such as hydrogen bonding, hydrophobic effects, Van der Waals forces, and sometimes ionic interactions. Modulation of SFR1 activity by these activators can lead to alterations in the rate of Fe-S cluster assembly or repair, which in turn can affect the numerous cellular pathways that depend on these clusters. The precise mechanisms by which SFR1 activators exert their effects are often complex, involving the interplay of multiple biochemical pathways and regulatory networks within the cell. Understanding the intricacies of these interactions and how they influence the function of SFR1 and its associated processes is a focus of research in the field of biochemistry and molecular biology.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin indirectly enhances the activity of SFR1 by elevating cAMP levels, which can activate PKA that may phosphorylate substrates relevant to SFR1's function. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA indirectly increases SFR1 activity by activating Protein Kinase C (PKC), which could phosphorylate substrates and affect pathways where SFR1 is involved. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin raises intracellular calcium levels, indirectly enhancing SFR1 by activating calcium-dependent signaling pathways that SFR1 may participate in. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a beta-adrenergic agonist, leads to cAMP accumulation, potentially activating PKA and enhancing SFR1 activity through downstream effects. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, leading to altered signaling dynamics that could indirectly upregulate SFR1's functional activity via effects on downstream pathways. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK1/2, potentially shifting signaling equilibria in a manner that indirectly enhances SFR1 activity through its involvement in related pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, which may allow for the enhancement of SFR1 activity by modulating pathways where SFR1 is a player. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG, as a kinase inhibitor, may indirectly enhance SFR1 activity by modulating signaling pathways in which SFR1 functions. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P modulates sphingolipid signaling, which could indirectly enhance SFR1 activity by influencing pathways that involve SFR1. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast increases cGMP levels, which might lead to the activation of PKG and indirectly enhance the activity of SFR1 by affecting signaling pathways it's involved in. | ||||||